JP2011527333A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011527333A5 JP2011527333A5 JP2011517247A JP2011517247A JP2011527333A5 JP 2011527333 A5 JP2011527333 A5 JP 2011527333A5 JP 2011517247 A JP2011517247 A JP 2011517247A JP 2011517247 A JP2011517247 A JP 2011517247A JP 2011527333 A5 JP2011527333 A5 JP 2011527333A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound
- compound according
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims 26
- 150000003839 salts Chemical class 0.000 claims 25
- 125000000217 alkyl group Chemical group 0.000 claims 7
- -1 2-hydroxy-1-methylethyl Chemical group 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 1
- 208000002705 Glucose Intolerance Diseases 0.000 claims 1
- 208000035150 Hypercholesterolemia Diseases 0.000 claims 1
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000006575 hypertriglyceridemia Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 201000009104 prediabetes syndrome Diseases 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 230000036186 satiety Effects 0.000 claims 1
- 235000019627 satiety Nutrition 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0812642.7 | 2008-07-10 | ||
| GBGB0812642.7A GB0812642D0 (en) | 2008-07-10 | 2008-07-10 | Compounds |
| PCT/GB2009/050829 WO2010004346A1 (en) | 2008-07-10 | 2009-07-10 | Piperidinyl gpcr agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011527333A JP2011527333A (ja) | 2011-10-27 |
| JP2011527333A5 true JP2011527333A5 (enExample) | 2012-08-16 |
Family
ID=39722068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011517247A Withdrawn JP2011527333A (ja) | 2008-07-10 | 2009-07-10 | ピペリジニルｇｐｃｒ作動薬 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20110195994A1 (enExample) |
| EP (1) | EP2318399B1 (enExample) |
| JP (1) | JP2011527333A (enExample) |
| CN (1) | CN102089299A (enExample) |
| AT (1) | ATE557023T1 (enExample) |
| ES (1) | ES2386870T3 (enExample) |
| GB (1) | GB0812642D0 (enExample) |
| WO (1) | WO2010004346A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ596445A (en) | 2009-06-24 | 2013-04-26 | Boehringer Ingelheim Int | New compounds, pharmaceutical composition and methods relating thereto |
| TW201113269A (en) | 2009-06-24 | 2011-04-16 | Boehringer Ingelheim Int | New compounds, pharmaceutical composition and methods relating thereto |
| WO2011113947A1 (en) | 2010-03-18 | 2011-09-22 | Boehringer Ingelheim International Gmbh | Combination of a gpr119 agonist and the dpp-iv inhibitor linagliptin for use in the treatment of diabetes and related conditions |
| TW201209054A (en) | 2010-05-28 | 2012-03-01 | Prosidion Ltd | Novel compounds |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| AR083904A1 (es) | 2010-11-18 | 2013-04-10 | Prosidion Ltd | Derivados de 1,4-pirrolidinas disustituidos y 3-il-aminas y sus usos en el tratamiento de desordenes metabolicos |
| GB201114389D0 (en) | 2011-08-22 | 2011-10-05 | Prosidion Ltd | Novel compounds |
| WO2012138845A1 (en) | 2011-04-08 | 2012-10-11 | Merck Sharp & Dohme Corp. | Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
| EP2720544B1 (en) | 2011-06-16 | 2016-12-21 | Merck Sharp & Dohme Corp. | Substituted cyclopropyl compounds, compositions containing such compounds, and methods of treatment |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760855B1 (en) | 2011-09-30 | 2017-03-15 | Merck Sharp & Dohme Corp. | Substituted cyclopropyl compounds, compositions containing such compounds as well as their use in treating type-2 diabetes |
| WO2013062838A1 (en) | 2011-10-24 | 2013-05-02 | Merck Sharp & Dohme Corp. | Substituted piperidinyl compounds useful as gpr119 agonists |
| AU2012339870B2 (en) | 2011-11-15 | 2017-06-29 | Merck Sharp & Dohme Corp. | Substituted cyclopropyl compounds useful as GPR119 agonists |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6100042A (en) * | 1993-03-31 | 2000-08-08 | Cadus Pharmaceutical Corporation | Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
| US6221660B1 (en) * | 1999-02-22 | 2001-04-24 | Synaptic Pharmaceutical Corporation | DNA encoding SNORF25 receptor |
| EP2308840A1 (en) * | 2005-06-30 | 2011-04-13 | Prosidion Limited | GPCR agonists |
| PE20081849A1 (es) * | 2007-01-04 | 2009-01-26 | Prosidion Ltd | Derivados de piperidin-4-il-propoxi-benzamida como agonistas de gpcr |
-
2008
- 2008-07-10 GB GBGB0812642.7A patent/GB0812642D0/en not_active Ceased
-
2009
- 2009-07-10 EP EP09785307A patent/EP2318399B1/en not_active Not-in-force
- 2009-07-10 AT AT09785307T patent/ATE557023T1/de active
- 2009-07-10 US US13/003,569 patent/US20110195994A1/en not_active Abandoned
- 2009-07-10 WO PCT/GB2009/050829 patent/WO2010004346A1/en not_active Ceased
- 2009-07-10 ES ES09785307T patent/ES2386870T3/es active Active
- 2009-07-10 JP JP2011517247A patent/JP2011527333A/ja not_active Withdrawn
- 2009-07-10 CN CN2009801269915A patent/CN102089299A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011527333A5 (enExample) | ||
| JP2010514829A5 (enExample) | ||
| JP2010514831A5 (enExample) | ||
| JP2011527332A5 (enExample) | ||
| JP2011527331A5 (enExample) | ||
| JP2010514832A5 (enExample) | ||
| JP2006143751A5 (enExample) | ||
| JP2018518537A5 (enExample) | ||
| JP2011527334A5 (enExample) | ||
| JP2012508215A5 (enExample) | ||
| JP2010077141A5 (enExample) | ||
| RU2011123365A (ru) | Соли финголимода | |
| RU2011123371A (ru) | Кристаллические формы гидрохлорида финголимода | |
| JP2011528658A5 (enExample) | ||
| JP2007508361A5 (enExample) | ||
| JP2011527335A5 (enExample) | ||
| RU2008127312A (ru) | Мезилатное пролекарство леводопы, его композиции и применение | |
| JP2009507909A5 (enExample) | ||
| JP2014511892A5 (enExample) | ||
| JP2009520690A5 (enExample) | ||
| JP2013542261A5 (enExample) | ||
| JP2010500293A5 (enExample) | ||
| RU2009122241A (ru) | Твердые формы рацемического илапразола | |
| JP2010504343A5 (enExample) | ||
| JP2010514806A5 (enExample) |